methyldopa has been researched along with Day Blindness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhathena, D; Holland, NH; Kotchen, T | 1 |
| Blake, DR; Cornish, A; Good, PA; Hider, RC; Kritzinger, EE; Lunec, J; Pall, H; Williams, A; Winyard, P | 1 |
2 other study(ies) available for methyldopa and Day Blindness
| Article | Year |
|---|---|
Hypertension in children with chronic pyelonephritis.
Topics: Blood Pressure; Child; Child, Preschool; Female; Humans; Hydralazine; Hypertension, Renal; Kidney; Male; Methyldopa; Neurologic Manifestations; Pyelonephritis; Radiography; Vesico-Ureteral Reflux; Vision Disorders | 1975 |
Ocular toxicity of desferrioxamine--an example of copper promoted auto-oxidative damage?
Topics: Aged; Copper; Deferoxamine; Electrooculography; Electroretinography; Evoked Potentials, Visual; Eye Diseases; Female; Humans; Male; Methyldopa; Middle Aged; Rheumatic Diseases; Serum Albumin; Vision Disorders | 1989 |